Showing results (281-290 of 392) with videos related to
Sort By:
Pageof 40
Aging|November 8, 2015
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibitionClemens Stockklausner, Simon Raffel, Julia Klermund, et al.International Journal of Cancer|December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive diseaseAnja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.Gerontology|May 1, 2022
Patient Acceptability of a Novel Technological Solution (Ambient Intelligent Geriatric Management System) to Prevent Falls in Geriatric and General Medicine Wards: A Mixed-Methods StudyJoanne Dollard, Keith D Hill, Anne Wilson, et al.Applied Health Economics and Health Policy|December 9, 2022
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in HospitalsClarabelle T Pham, Renuka Visvanathan, Mark Strong, et al.Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|January 15, 2024
Community pharmacists' perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains frameworkJaclyn Tran, Connor Shaffelburg, Emma Phelan, et al.Journal of Public Health Dentistry|June 26, 2014
Learning from caries-free children in a high-caries American Indian populationJudith Albino, Tamanna Tiwari, William G Henderson, et al.Nature Communications|March 2, 2021
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomicsLars Velten, Benjamin A Story, Pablo Hernández-Malmierca, et al.Clinical and Translational Science|November 3, 2023
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacyNicolas Hohmann, Martin Ronald Sprick, Moritz Pohl, et al.Blood|April 21, 2012
Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cellsIngmar Bruns, Ron-Patrick Cadeddu, Ines Brueckmann, et al.Nature Cancer|February 5, 2022
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancerMengyu Tu, Lukas Klein, Elisa Espinet, et al.Pageof 40